Ausgabe 3/2020
Inhalt (10 Artikel)
Integration of Patient Reported Outcomes in Drug Development in Genitourinary Cancers
Risa L. Wong, Alicia K. Morgans
Current State of Systemic Therapies for Advanced Renal Cell Carcinoma
Shuchi Gulati, Ulka Vaishampayan
Androgen Deprivation Therapy and Cognitive Function in Prostate Cancer
Jonathan Kluger, Alicia Roy, Herta H. Chao
Prognostic Biomarkers for Melanoma Immunotherapy
Christopher G. Twitty, Laura A. Huppert, Adil I. Daud
Lymphadenectomy in Ovarian Cancer: Is It Still Justified?
Pierluigi Benedetti Panici, Andrea Giannini, Margherita Fischetti, Francesca Lecce, Violante Di Donato
Management of Stage IIB Cervical Cancer: an Overview of the Current Evidence
Shinya Matsuzaki, Maximilian Klar, Mikio Mikami, Muneaki Shimada, Brendan H. Grubbs, Keiichi Fujiwara, Lynda D. Roman, Koji Matsuo
PARP Inhibitors in Gynecologic Cancers: What Is the Next Big Development?
Michelle Lightfoot, Lauren Montemorano, Kristin Bixel
Acute Myeloid Leukaemia in Its Niche: the Bone Marrow Microenvironment in Acute Myeloid Leukaemia
E. E. Ladikou, H. Sivaloganathan, A. Pepper, T. Chevassut
Proton Beam Therapy in Liver Malignancies
Osman Siddiqui, Ariel Pollock, Santanu Samanta, Adeel Kaiser, Jason K. Molitoris
Integrative Approaches to Chemotherapy-Induced Peripheral Neuropathy
Noah Samuels, Eran Ben-Arye